REORGANIZATION OF SPINAL INHIBITORY SYNAPTIC CIRCUITS AFTER NERVE INJURY

神经损伤后脊髓抑制突触回路的重组

基本信息

  • 批准号:
    8627653
  • 负责人:
  • 金额:
    $ 24.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-15 至
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY (See Instructions): After peripheral nerve injuries axons can regenerate and reestablish connectivity in the periphery; however restored motor function is not normal. Previously we have shown that some deficits, like lack of monosynaptic reflexes, can be explained by the permanent retraction of la proprioceptive synapses from motoneurons. We now propose that circuit reorganizations are relatively global and affect also spinal intermeuronal circuits that exert control over not only injured motoneurons, but also other motor pools controlling the same limb. As a result, a novel limb control pattern emerges that allows some function, but is also clearly pathological. In the proposed work we will seek confirmation for structural changes in spinal interneuronal circuits. The work will parallel functional studies proposed in project 1. We will analyze in detail the synaptic organization of recurrent and reciprocal inhibition, two key inhibitory circuits that modulate and pattern motoneuron firing and therefore muscle contractions. Recurrent inhibition exerts feedback control of motor output through an interposed interneuron named the Renshaw cell that receives direct excitation from intraspinal collaterals of motor axons. Reciprocal inhibition is mediated by la inhibitory interneurons which receive common inputs with certain motor pools, including those from la afferents, and inhibit motoneurons with antagonist action allowing for example smooth flexion-extension alternation during movement. We hypothesize that both interneurons become denervated from respectively, motor axons and la afferents after nerve injury. We propose that these alterations cause major changes in spinal circuitry. In aim 1 we will test the hypothesis that denervation of Renshaw cells coupled to injured motor axons causes synaptic reorganizations of recurrent inhibition in the whole spinal segment. In aim 2 we will test the hypothesis that differential la de-afferentation of inhibitory and excitatory interneurons in reciprocal pathways causes a shift in balance favoring excitation. These could explain the excessive co-contraction of antagonists observed after nerve injuries. Detail analyses of connectivity will be performed with a combination of techniques, including novel retrograde transynaptic viral tracing that allows revealing microcircuit connectivity.
项目总结(见说明):周围神经损伤后,轴突可以再生并重新建立周围的连接;然而,恢复的运动功能是不正常的。以前,我们已经表明,一些缺陷,如缺乏单突触反射,可以解释为永久回缩的LA本体感受突触从运动神经元。我们现在提出,电路重组是相对全球性的,也影响脊髓神经元间回路,不仅对受伤的运动神经元施加控制,但也控制同一肢体的其他运动池。结果,一种新的肢体控制模式出现了,它允许一些功能,但也明显是病态的。在拟议的工作中,我们将寻求确认脊髓神经元间回路的结构变化。这项工作将与项目1中提议的功能研究并行进行。我们将详细分析复发性和相互抑制的突触组织,这两个关键的抑制回路调节和模式运动神经元放电,因此肌肉收缩。复发性抑制通过一个名为Renshaw细胞的中间神经元对运动输出进行反馈控制,该中间神经元从运动轴突的脊髓内侧支接受直接兴奋。相互抑制由la抑制性中间神经元介导,所述la抑制性中间神经元接收与某些运动池(包括来自la传入的那些)共同的输入,并且用拮抗剂作用抑制运动神经元,从而允许例如在运动期间平滑的屈曲-伸展交替。我们假设,这两个中间神经元成为失神经分别从运动轴突和la传入神经损伤后。我们认为,这些改变导致脊髓回路的重大变化。在目标1中,我们将测试的假设,Renshaw细胞耦合到受损的运动轴突的神经支配导致突触重组的复发性抑制在整个脊髓节段。在目标2中,我们将检验以下假设:在相互通路中,抑制性和兴奋性中间神经元的差异性去传入导致有利于兴奋的平衡的转变。这些可以解释神经损伤后观察到的拮抗剂的过度共收缩。详细的连接分析将与技术的组合,包括新的逆行跨突触病毒示踪,允许揭示微电路连接。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FRANCISCO J ALVAREZ其他文献

FRANCISCO J ALVAREZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FRANCISCO J ALVAREZ', 18)}}的其他基金

Disruption of spinal circuit early development after silencing En1/Foxp2 interneurons
沉默 En1/Foxp2 中间神经元后脊髓回路早期发育中断
  • 批准号:
    10752857
  • 财政年份:
    2023
  • 资助金额:
    $ 24.29万
  • 项目类别:
Neuroinflammation grading and adjusting of spinal sensorimotor circuitries in response to remote injuries in peripheral nerves
神经炎症分级和脊髓感觉运动回路的调整以应对周围神经的远程损伤
  • 批准号:
    9885850
  • 财政年份:
    2020
  • 资助金额:
    $ 24.29万
  • 项目类别:
Neuroinflammation Grading and Adjusting of Spinal Sensorimotor Circuitries in Response to Remote Injuries in Peripheral Nerves
神经炎症分级和脊髓感觉运动回路响应周围神经远程损伤的调整
  • 批准号:
    10559555
  • 财政年份:
    2020
  • 资助金额:
    $ 24.29万
  • 项目类别:
Neuroinflammation Grading and Adjusting of Spinal Sensorimotor Circuitries in Response to Remote Injuries in Peripheral Nerves
神经炎症分级和脊髓感觉运动回路响应周围神经远程损伤的调整
  • 批准号:
    10341146
  • 财政年份:
    2020
  • 资助金额:
    $ 24.29万
  • 项目类别:
Inhibitory synapses and axon regeneration in adults after injury-induced axotomy
成人损伤诱导轴突切除术后的抑制性突触和轴突再生
  • 批准号:
    10020198
  • 财政年份:
    2019
  • 资助金额:
    $ 24.29万
  • 项目类别:
Spinal cord neuroinflammation and synaptic plasticity after peripheral nerve injury
周围神经损伤后脊髓神经炎症和突触可塑性
  • 批准号:
    9512062
  • 财政年份:
    2017
  • 资助金额:
    $ 24.29万
  • 项目类别:
Multi-photon laser scanning microscope
多光子激光扫描显微镜
  • 批准号:
    7498307
  • 财政年份:
    2009
  • 资助金额:
    $ 24.29万
  • 项目类别:
REORGANIZATION OF SPINAL INHIBITORY SYNAPTIC CIRCUITS AFTER NERVE INJURY
神经损伤后脊髓抑制突触回路的重组
  • 批准号:
    8562551
  • 财政年份:
    2007
  • 资助金额:
    $ 24.29万
  • 项目类别:
Olympus FV 1000 Confocal Microscope for Neurobiology and Cellular Biology Researc
用于神经生物学和细胞生物学研究的奥林巴斯 FV 1000 共焦显微镜
  • 批准号:
    7047364
  • 财政年份:
    2006
  • 资助金额:
    $ 24.29万
  • 项目类别:
OLYMPUS FV 1000 CONFOCAL MICROSCOPE FOR NEUROBIOLOGY AND CELLULAR BIOLOGY RESEAR
用于神经生物学和细胞生物学研究的奥林巴斯 FV 1000 共焦显微镜
  • 批准号:
    7335244
  • 财政年份:
    2006
  • 资助金额:
    $ 24.29万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 24.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 24.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 24.29万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 24.29万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 24.29万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 24.29万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 24.29万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 24.29万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 24.29万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 24.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了